Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Myriad Genetics (MYGN) Shares Repurchased (2016)

Myriad Genetics (MYGN) has disclosed Shares Repurchased for 7 consecutive years, with $10.3 million as the latest value for Q4 2016.

  • On a quarterly basis, Shares Repurchased fell 58.63% to $10.3 million in Q4 2016 year-over-year; TTM through Mar 2019 was $10.3 million, a N/A change, with the full-year FY2019 number at $50.0 million, changed N/A from a year prior.
  • Shares Repurchased was $10.3 million for Q4 2016 at Myriad Genetics, down from $21.3 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $102.3 million in Q3 2013 to a low of $10.3 million in Q4 2016.
  • A 5-year average of $45.6 million and a median of $44.9 million in 2013 define the central range for Shares Repurchased.
  • Biggest YoY gain for Shares Repurchased was 273.36% in 2013; the steepest drop was 64.6% in 2013.
  • Myriad Genetics' Shares Repurchased stood at $33.7 million in 2012, then surged by 130.99% to $77.8 million in 2013, then decreased by 25.07% to $58.3 million in 2014, then plummeted by 57.29% to $24.9 million in 2015, then plummeted by 58.63% to $10.3 million in 2016.
  • Per Business Quant, the three most recent readings for MYGN's Shares Repurchased are $10.3 million (Q4 2016), $21.3 million (Q3 2016), and $54.7 million (Q2 2016).